BMS2110 Theory 18: Cell Signalling 3 - Enzyme-Coupled Receptors
Molecular Foundations: Phosphate and Molecular Switches
The Phosphate Group: * Phosphate is a widely abundant molecule involved in a vast array of cellular processes. * Chemical Composition: It is composed of Phosphorus atom and Oxygen atoms (). * Phosphorylation: This group can be attached to other molecules to form a phosphate group, a critical modification for signaling. * High-Energy Nucleosides: When three phosphate groups are linked to specific nucleosides, they form: * Adenosine triphosphate (ATP). * Guanosine triphosphate (GTP).
Molecular Switches: GEF and GAP: * The presence of GTP or GDP determines whether a signaling protein is in an "on" or "off" state. * GDP-bound state: The protein is inactive (OFF). * GTP-bound state: The protein is active (ON). * Guanine Exchange Factor (GEF): This enzyme activates the protein by removing the bound GDP and allowing GTP to take its place. * GTPase-activating proteins (GAP): This enzyme inactivates the protein by inducing GTP hydrolysis, converting GTP back into GDP.
Enzyme-Coupled Receptors: Structure and Classification
Functional Overview: * Enzyme-coupled receptors are cell surface receptors where the binding of an extracellular signal either activates the receptor's own catalytic domain or leads to the activation of an associated enzyme.
Three Key Domains of Enzyme-Coupled Receptors: * Ligand-Binding Domain: The extracellular region that allows for easy access and activation by signal molecules. * Transmembrane Domain: A series of hydrophobic amino acids that tethers the receptor securely to the cell membrane. * Intracellular Domain: This region either contains intrinsic catalytic (enzymatic) activity or is tightly bound to an enzyme to propagate the signal.
Types of Enzyme-Coupled Receptors: 1. Receptor tyrosine kinases (RTKs). 2. Tyrosine-kinase-associated receptors. 3. Receptor-like tyrosine phosphatases. 4. Receptor serine/threonine kinases. 5. Receptor guanylyl cyclases. 6. Histidine-kinase-associated receptors.
Receptor Tyrosine Kinases (RTKs)
Scale and Function: * The human genome encodes distinct RTKs. * These are organized into different subfamilies. * RTKs regulate fundamental physiological functions including cell proliferation, differentiation, cell adhesion, migration, survival, and apoptosis.
Key Enzymes in RTK Signaling: * Kinases: Enzymes that transfer a phosphate group from ATP to a specific substrate, a process known as Phosphorylation. * Phosphatases: Enzymes that remove phosphate groups from other molecules, a process known as Dephosphorylation.
RTK Activation Mechanism: * Step 1: Dimerization: In the inactive form (absence of signal), RTK units exist as monomers. Upon ligand binding, the receptors form dimers. This can be a homodimer (two identical versions) or a heterodimer (two closely related but non-identical versions). Some signal monomers can also form a dimer before binding. * Step 2: Cross-Phosphorylation: Once the dimer is formed, the tyrosine kinase domain in the intracellular region is activated. The receptor units perform cross-phosphorylation (autophosphorylation), where each unit in the dimer phosphorylates tyrosine residues on the opposing unit. * Step 3: Protein Docking: The phosphorylated tyrosine residues serve as specific docking sites for intracellular signaling proteins. These docked proteins bind, become activated (often through their own phosphorylation), and relay the signal downstream.
SH2 Domains: * Intracellular signaling proteins that dock on activated RTKs typically bind to the phosphorylated tyrosines via Src Homology 2 (SH2) domains.
The RAS–MAPK Pathway
Ligands Activating RTKs: * EGF (Epidermal growth factor). * PDGF (Platelet-derived growth factor). * NGF (Nerve growth factor). * IGF (Insulin-like growth factor). * Insulin. * FGF (Fibroblast growth factor). * VEGF (Vascular endothelial growth factor).
The Small GTPase Ras: * Ras is the first molecule commonly activated after RTKs. * It acts as a molecular switch, alternating between active GTP-bound and inactive GDP-bound forms. * GTP-bound Ras associates with the plasma membrane, diffuses laterally, and activates surface-level proteins.
MAPK Cascade: * Ras initiates a chain reaction of phosphorylation events involving Mitogen-activated protein kinases (MAPKs). * Scaffolds: MAPKs are often held together by scaffold proteins to ensure the specificity and efficiency of the activation chain. * The EGF Signaling Chain: 1. EGF binds to the EGFR (RTK). 2. Grb2 and SOS (a GEF) facilitate the activation of Ras. 3. Ras activates Raf (a MAPKKK). 4. Raf activates MEK (a MAPKK). 5. MEK activates ERK (a MAPK). 6. ERK phosphorylates various cytosolic and nuclear proteins to promote cell growth and division.
Clinical Relevance: Cancer and Ras Mutations
Oncogenic Mutations: * Ras is mutated in many cancers. * Common mutations alter the amino acids Glycine 12/13 or Glutamine 61. * Mutant Ras remains locked in the GTP-bound (Active) state, leading to excessive proliferation and cancer initiation.
Therapeutic Approaches: * Direct inhibitors targeting mutant Ras proteins. * Combination therapies using KRAS inhibitors with agents targeting other proteins in the signaling pathway. * Development of cancer vaccines and small interfering RNAs (siRNAs) centered on oncogenic Ras.
PI3K-AKT Pathway and Insulin Signaling
Mechanism of Activation: * The Insulin receptor (an RTK) activates IRS (Insulin receptor substrate). * IRS recruits the enzyme PI3 Kinase (PI3K) to the plasma membrane. * PI3K phosphorylates the second messenger PIP2 (Phosphatidylinositol 4,5-bisphosphate), converting it into PIP3 (Phosphatidylinositol (3,4,5)-trisphosphate). * PIP3 recruits the serine/threonine protein kinase AKT (also known as PKB) to the plasma membrane. * PDPK1 (PDK1) phosphorylates AKT at residue Threonine 308.
Physiological Outcomes of AKT Activation: * Activated AKT promotes cell survival, growth, proliferation, and metabolic changes. * Downstream targets of AKT include FOXO, TSC2, GSK3B, TBC1D4, mTORC1, SREBP1C, and S6K.
Systemic Effects of Insulin Signalling by Tissue: * Liver: Decreases glucose production; increases glucose utilization, fatty acid synthesis, protein synthesis, and glycogen synthesis. * Fat: Increases glucose uptake and triglyceride (TG) synthesis; decreases lipolysis. * Muscle: Increases glucose uptake, protein synthesis, and muscle mass. * Brain: Regulates activity and food intake. * Macrophage: Increases scavenger receptor A, ER stress, and apoptosis. * Endothelial Cells: Increases Nitric Oxide () synthesis; affects cell adhesion and inflammation. * B-cell: Increases cell mass; decreases apoptosis and dedifferentiation. * Overall homeostasis involves the regulation of hepatic glucose production and lipoprotein production.